1. Urate reduction with allopurinol did not slow the decline of estimated glomerular filtration rate (eGFR) compared to the placebo treatment in patients with chronic kidney disease.
2. The urinary albumin:creatinine ratio was shown not to be significantly different between the treatment groups.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Increased risk...